Current pharma model “not sustainable” during COVID-19, says Daiichi’s UK leadAt eyeforpharma Daiichi Sankyo’s Manuel Reiberg spoke about why the industry should look to make drugs more affordable Share XCurrent pharma model “not sustainable” during COVID-19, says Daiichi’s UK leadhttps://pharmaphorum.com/news/current-pharma-model-not-sustainable-during-covid-19-says-daiichis-uk-lead/
Why Norgine is embracing AI chatbots for medical informationWhen European pharma company Norgine saw an unmet need in how patients were seeking information on one of Share XWhy Norgine is embracing AI chatbots for medical informationhttps://pharmaphorum.com/views-analysis-digital/norgine-embracing-ai-chatbot/
Equal coronavirus vaccine access a “real issue”Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided Share XEqual coronavirus vaccine access a “real issue”https://pharmaphorum.com/news/equal-coronavirus-vaccine-access-real-issue/
COVID-19 the time for digital health companies to “prove their worth”Digital startup guru Jessica Federer has called on pharma to see the COVID-19 crisis as an opportunity to Share XCOVID-19 the time for digital health companies to “prove their worth”https://pharmaphorum.com/news/covid-19-digital-health-companies-prove-their-worth/
COVID-19 could cause ‘digital reset’ for pharmaThe COVID-19 crisis will lead to a “digital reset” in pharma that will completely change how companies interact Share XCOVID-19 could cause ‘digital reset’ for pharmahttps://pharmaphorum.com/news/covid-19-digital-reset-for-pharma/
Pharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they Share XPharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’https://pharmaphorum.com/news/pharma-companies-that-dont-change-during-covid-19-will-be-new-kodaks-of-this-world/
The many faces of patient-pharma co-creationAhead of her appearance at eyeforpharma Barcelona, Merck’s director of patient advocacy and strategic partnerships, Vanessa Pott, tells Share XThe many faces of patient-pharma co-creationhttps://pharmaphorum.com/views-analysis-patients/the-many-faces-of-patient-pharma-co-creation-merck-eyeforpharma/
eyeforpharma Patient Summit Europe roundupeyeforpharma’s Patient Summit Europe brought together leading patient innovators from industry and patient associations for two days of Share Xeyeforpharma Patient Summit Europe rounduphttps://pharmaphorum.com/views-analysis-patients/eyeforpharma-patient-summit-europe-roundup/
Real world evidence, digital partnerships and the future of pharmaAhead of the eyeforpharma Awards we spoke to judge Jennifer Wong – AstraZeneca’s senior director, RWE strategy & Share XReal world evidence, digital partnerships and the future of pharmahttps://pharmaphorum.com/views-analysis-digital/real-world-evidence-digital-partnerships-and-the-future-of-pharma/
